Differential activation of NF-κB and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 6 47-6, 2003, Pages

  Chen, Shali ^a   Khan, Zia Ali ^a   Cukiernik, Mark ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Activating protein 1; Diabetes; Endothelin; Heart; Kidney; Nuclear factor B; Retina

Indexed keywords

BOSENTAN; ENDOTHELIN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION;

EID: 0038516909     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00540.2002     Document Type: Article

References (41)

1. Bowie A and O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59: 13-23, 2000.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
3. Cagliero E, Roth T, Roy S, Maiello M, and Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem 266: 14244-14250, 1991.
4. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, and Chen S. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16: 393-407, 2000.
5. Chakrabarti S and Sima AA. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats. Diabetes 38: 1181-1186, 1989.
6. Chen F, Castranova V, and Shi X. New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159: 387-397, 2001.
7. Chen S, Apostolova MD, Cherian MG, and Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest 80: 1311-1321, 2000.
8. Chen S, Evans T, Deng D, Cukiernik M, and Chakrabarti S. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 90: 86-94, 2002.
9. Chen S, Evans T, Mukherjee K, Karmazyn M, and Chakrabarti S. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell Cardiol 32: 1621-1629, 2000.
10. Chen S, Mukherjee S, Chakraborty C, and Chakrabarti S. High glucose-induced, endothelin-dependent, extracellular matrix protein synthesis is mediated via nuclear factor-κB and AP-1. Am J Physiol Cell Physiol 284: C263-C272, 2003.
11. Chinenov Y and Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452, 2001.
12. Deng D, Evans T, Mukherjee K, Downey D, and Chakrabarti S. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia 42: 1228-1234, 1999.
13. Dignam JD, Lebovitz RM, and Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
14. Engerman RL, Kern TS, and Garment MB. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. J Diabetes Complications 7: 241-245, 1993.
15. Evans T, Deng DX, Chen S, and Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 49: 662-666, 2000.
16. Gallois C, Habib A, Tao J, Moulin S, Maclouf J, Mallat A, and Lotersztajn S. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 273: 23183-23190, 1998.
17. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben Neriah Y, and Baeuerle PA. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365: 182-185, 1993.
18. Ishii H, Koya D, and King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76: 21-31, 1998.
19. Jones S, Jones S, and Phillips AO. Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int 59: 1739-1749, 2001.
20. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, and Adamis AP. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16: 438-440, 2002.
21. King GL and Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-270, 1996.
22. Kornblihtt AR, Umezawa K, Vibe-Pedersen K, and Baralle FE. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 4: 1755-1759, 1985.
23. Kumar A, Hawkins KS, Hannan MA, and Ganz MB. Activation of PKC-βI in glomerular mesangial cells is associated with specific NF-κB subunit translocation. Am J Physiol Renal Physiol 281: F613-F619, 2001.
24. Lal MA, Brismar H, Eklof AC, and Aperia A. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 61: 2006-2014, 2002.
25. Lee BH, Kim MS, Rhew JH, Park RW, de Crombrugghe B, and Kim IS. Transcriptional regulation of fibronectin gene by phorbol myristate acetate in hepatoma cells: a negative role for NF-kappaB. J Cell Biochem 76: 437-451, 2000.
26. Levin ER. Endothelins. N Engl J Med 333: 356-363, 1995.
27. Levin ER. Endothelins as cardiovascular peptides. Am J Nephrol 16: 246-251, 1996.
28. Madri JA, Pratt BM, and Yannariello-Brown J. Matrixdriven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol 132: 18-27, 1988.
29. Mizutani M, Kern TS, and Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883-2890, 1996.
30. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, and Nawroth PP. The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10: 157-167, 1999.
31. Muller DN, Mullally A, Dechend R, Park JK, Fiebeler A, Pilz B, Loffler BM, Blum-Kaelin D, Masur S, Dehmlow H, Aebi JD, Haller H, and Luft FC. Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 40: 840-846, 2002.
32. Nishio Y, Kashiwagi A, Taki H, Shinozaki K, Maeno Y, Kojima H, Maegawa H, Haneda M, Hidaka H, Yasuda H, Horiike K, and Kikkawa R. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes 47: 1318-1325, 1998.
33. Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, and Nawroth PP. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes 49: 1561-1570, 2000.
34. Romeo G, Liu WH, Asnaghi V, Kern TS, and Lorenzi M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51: 2241-2248, 2002.
35. Roux S, Breu V, Ertel SI, and Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 77: 364-376, 1999.
36. Roy S, Cagliero E, and Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 37: 258-266, 1996.
37. Schreiber E, Matthias P, Muller MM, and Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989.
38. Shaulian E and Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
39. Shono T, Ono M, Izumi H, Jimi SI, Matsushima K, Okamoto T, Kohno K, and Kuwano M. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 16: 4231-4239, 1996.
40. Tamura K, Nyui N, Tamura N, Fujita T, Kihara M, Toya Y, Takasaki I, Takagi N, Ishii M, Oda K, Horiuchi M, and Umemura S. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem 273: 26487-26496, 1998.
41. Yamada KM. Cell surface interactions with extracellular materials. Annu Rev Biochem 52: 761-799, 1983.